0000950142-05-000299.txt : 20120725
0000950142-05-000299.hdr.sgml : 20120725
20050208155445
ACCESSION NUMBER: 0000950142-05-000299
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20050208
DATE AS OF CHANGE: 20050208
GROUP MEMBERS: JEFFREY THORP
GROUP MEMBERS: LANGLEY CAPITAL, LLC
GROUP MEMBERS: LANGLEY MANAGEMENT, LLC
GROUP MEMBERS: LANGLEY PARTNERS, L.P.
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: VION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000944522
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 133671221
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-46031
FILM NUMBER: 05584032
BUSINESS ADDRESS:
STREET 1: 4 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 2034984210
MAIL ADDRESS:
STREET 1: FOUR SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
FORMER COMPANY:
FORMER CONFORMED NAME: ONCORX INC
DATE OF NAME CHANGE: 19950615
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: LANGLEY PARTNERS LP
CENTRAL INDEX KEY: 0001142500
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 535 MADISON AVENUE
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-850-7528
SC 13G/A
1
sc13ga1-vion.txt
AMENDMENT NO. 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Vion Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
927624106
(CUSIP Number)
December 31, 2004
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 927624106 2
--------------------------------------------------------------------------------
1. Name of Reporting Person:
Langley Partners, L.P.
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group:
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization: Delaware
--------------------------------------------------------------------------------
5. Sole Voting Power: -0-
Number of
Shares --------------------------------------------------------
Beneficially 6. Shared Voting Power: 1,996,170 (see Item 4)
Owned By
Each --------------------------------------------------------
Reporting 7. Sole Dispositive Power: -0-
Person
With --------------------------------------------------------
8. Shared Dispositive Power: 1,996,170 (see Item 4)
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person:
1,996,170
--------------------------------------------------------------------------------
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares:
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9): 2.9%
--------------------------------------------------------------------------------
12. Type of Reporting Person: PN
--------------------------------------------------------------------------------
CUSIP No. 927624106 3
--------------------------------------------------------------------------------
1. Name of Reporting Person:
Langley Management, LLC
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group:
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization: Delaware
--------------------------------------------------------------------------------
5. Sole Voting Power: -0-
Number of
Shares --------------------------------------------------------
Beneficially 6. Shared Voting Power: 1,996,170 (see Item 4)
Owned By
Each --------------------------------------------------------
Reporting 7. Sole Dispositive Power: -0-
Person
With --------------------------------------------------------
8. Shared Dispositive Power: 1,996,170 (see Item 4)
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person:
1,996,170
--------------------------------------------------------------------------------
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares:
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9): 2.9%
--------------------------------------------------------------------------------
12. Type of Reporting Person: OO
--------------------------------------------------------------------------------
CUSIP No. 927624106 4
--------------------------------------------------------------------------------
1. Name of Reporting Person:
Langley Capital, LLC
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group:
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization: Delaware
--------------------------------------------------------------------------------
5. Sole Voting Power: -0-
Number of
Shares --------------------------------------------------------
Beneficially 6. Shared Voting Power: 1,996,170 (see Item 4)
Owned By
Each --------------------------------------------------------
Reporting 7. Sole Dispositive Power: -0-
Person
With --------------------------------------------------------
8. Shared Dispositive Power: 1,996,170 (see Item 4)
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person:
1,996,170
--------------------------------------------------------------------------------
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares:
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9): 2.9%
--------------------------------------------------------------------------------
12. Type of Reporting Person: OO
--------------------------------------------------------------------------------
CUSIP No. 927624106 5
--------------------------------------------------------------------------------
1. Name of Reporting Person:
Jeffrey Thorp
--------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group:
(a) [_]
(b) [X]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization: United States
--------------------------------------------------------------------------------
5. Sole Voting Power: -0-
Number of
Shares --------------------------------------------------------
Beneficially 6. Shared Voting Power: 1,996,170 (see Item 4)
Owned By
Each --------------------------------------------------------
Reporting 7. Sole Dispositive Power: -0-
Person
With --------------------------------------------------------
8. Shared Dispositive Power: 1,996,170 (see Item 4)
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person:
1,996,170
--------------------------------------------------------------------------------
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares:
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9): 2.9%
--------------------------------------------------------------------------------
12. Type of Reporting Person: IN
--------------------------------------------------------------------------------
CUSIP No. 927624106 6
This Amendment No. 1 to Schedule 13G is filed by the undersigned to amend and
restate in its entirety the Schedule 13G, dated Febraury 19, 2004, with respect
to the shares of Common Stock, par value $0.01 per share, of Vion
Pharmaceuticals, Inc.
Item 1(a). Name of Issuer:
Vion Pharmaceuticals, Inc. (the "Company").
Item 1(b). Address of Issuer's Principal Executive Offices:
4 Science Park
New Haven, CT 06511
Item 2(a). Name of Persons Filing:
(i) Langley Partners, L.P. ("Langley L.P."), (ii) Langley
Management, LLC, (iii) Langley Capital, LLC and (iv) Jeffrey
Thorp ("Thorp", together with Langley L.P., Langley
Management, LLC and Langley Capital, LLC, the "Reporting
Persons").
Item 2(b). Address of Principal Business Office:
For each Reporting Person:
535 Madison Avenue
7th Floor
New York, NY 10022.
Item 2(c). Citizenship:
See row 4 of each Reporting Person's cover page.
Item 2(d). Title of Class of Securities:
Common Stock, $0.01 par value per share, of the Company
Item 2(e). CUSIP Number:
927624106
Item 3. Not applicable.
Item 4. Ownership.
For each Reporting Person:
(a) Amount beneficially owned:
1,996,170 shares of Common Stock issuable to Langley
L.P. upon exercise of warrants.
CUSIP No. 927624106 7
Langley Capital, LLC is the general partner of
Langley L.P. Thorp is the sole member and manager of
Langley Capital, LLC. Langley Management, LLC is the
investment manager of Langley L.P. Thorp holds a
99.9% membership interest in Langley Management, LLC
and is the sole manager thereof. As a result, each of
Langley Management, LLC, Langley Capital, LLC and
Thorp are considered to share the power to vote or
direct the vote of, and the power to dispose or
direct the disposition of, the shares of Common Stock
directly beneficially owned by Langley L.P. This
statement on Schedule 13G shall not be construed as
an admission that any of the Reporting Persons (other
than Langley L.P.) is the beneficial owner of the
Common Stock covered by this statement.
(b) Percent of class:
2.9% of the total outstanding shares of Common Stock.
This percentage is based upon the 67,856,483 shares
of Common Stock issued and outstanding, which number
is calculated by adding (i) 55,860,313 (the number of
shares of Common Stock reported in Amendment No. 1 to
the Company's registration statement on Form S-3
filed January 7, 2005) (ii) 1,996,170 (the number of
shares of Common Stock issuable to Langley L.P. upon
exercise of its warrants), and (iii) 10,000,000 (the
number of shares of Common Stock offered for sale to
the public as reported in the Company's prospectus
supplement filed January 26, 2005 pursuant to Rule
424(b)).
(c) Number of shares to which each Reporting Person has:
(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote:
1,996,170
(iii) Sole power to dispose or to direct the
disposition of: -0-
(iv) Shared power to dispose of or direct the
disposition of: 1,996,170
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities check the following [X].
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported By the Parent Holding
Company.
Not Applicable.
Item 8. Identification and Classification of Members of the Group.
CUSIP No. 927624106 8
Not Applicable.
Item 9. Notice of Dissolution of a Group.
Not Applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: February 8, 2005
LANGLEY PARTNERS, L.P.
By: LANGLEY CAPITAL, LLC,
as General Partner
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
LANGLEY MANAGEMENT, LLC
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
LANGLEY CAPITAL, LLC
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
/s/ Jeffrey Thorp
-------------------------------------------
Jeffrey Thorp
EX-99
2
ex1_sc13ga1-vion.txt
EXHIBIT 1
EXHIBIT 1
---------
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of
1934, as amended, the undersigned agree to the joint filing on behalf of each of
them of a statement on Schedule 13G (including amendments thereto) with respect
to the Common Stock, par value $0.01 per share, of Vion Pharmaceuticals, Inc.,
and further agree that this Joint Filing Agreement shall be included as an
exhibit to such joint filings.
The undersigned further agree that each party hereto is responsible for
the timely filing of such Schedule 13G and any amendments thereto, and for the
completeness and accuracy of the information concerning such party contained
therein; provided, however, that no party is responsible for the completeness or
accuracy of the information concerning any other party making the filing, unless
such party knows or has reason to believe that such information is inaccurate.
IN WITNESS WHEREOF, the parties have executed this Joint Filing
Agreement on February 8, 2005.
LANGLEY PARTNERS, L.P.
By: LANGLEY CAPITAL, LLC,
as General Partner
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
LANGLEY MANAGEMENT, LLC
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
LANGLEY CAPITAL, LLC
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
/s/ Jeffrey Thorp
-------------------------------------------
Jeffrey Thorp